Fruquitinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fruquitinib, covering 2022-07-25 to 2022-07-25. Get the full timeline:
Most recent: Clinical Trial Update: Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer [Phase 2]